SCHEMBL657333

SCHEMBL657333

O=C(O)C=C(CCc1ccc(Cl)cc1Cl)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 8/20 1.00
TBXA2R P21731 1/20 0.47
PTGFR P43088 1/20 0.47
PTGER3 P43115 1/20 0.47
PTGER2 P43116 1/20 0.47
PTGIR P43119 1/20 0.47
PTGDR Q13258 1/20 0.47
HPGD P15428 1/20 0.47
MAPT P10636 1/20 0.46
PLAAT3 P53816 1/20 0.46
PLAAT5 Q96KN8 1/20 0.46
PLAAT2 Q9NWW9 1/20 0.46
PLAAT4 Q9UL19 1/20 0.46
NR4A2 P43354 2/20 0.44
NR4A1 P22736 1/20 0.44
NR4A3 Q92570 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL657331 1.00 PDPK1 (1.00) PDPK1TBXA2RPTGFRPTGER3PTGER2
SCHEMBL657332 1.00 PDPK1 (1.00) PDPK1TBXA2RPTGFRPTGER3PTGER2
SCHEMBL657708 0.86 PDPK1 (0.76) PDPK1TBXA2RPTGFRPTGER3PTGER2
SCHEMBL657709 0.86 PDPK1 (0.76) PDPK1TBXA2RPTGFRPTGER3PTGER2
SCHEMBL657710 0.86 PDPK1 (0.76) PDPK1TBXA2RPTGFRPTGER3PTGER2
SCHEMBL29579676 0.81 PDPK1 (0.68) PDPK1HPGDMAPTPLAAT3PLAAT5
SCHEMBL658196 0.81 PDPK1 (0.68) PDPK1HPGDMAPTPLAAT3PLAAT5
SCHEMBL10253350 0.80 PDPK1 (0.67) PDPK1TBXA2RPTGFRPTGER3PTGER2
SCHEMBL657792 0.80 PDPK1 (1.00) PDPK1PLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL657791 0.80 PDPK1 (1.00) PDPK1PLAAT3PLAAT5PLAAT2PLAAT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB PDPK1 109/4885TBXA2R 3445/4885PTGFR 3829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.